Dr. Danielle Marie Bertoni, MD

Dr. Bertoni practices at John Muir Medical Center, Walnut Creek in Walnut Creek, California, part of John Muir Health.

Dr. Bertoni's NPI, 1780843185, was assigned on June 2, 2008. Dr. Bertoni graduated from Rutgers New Jersey Medical School in 2007. Dr. Bertoni holds California license A105375.

Dr. Bertoni's primary practice is John Muir Medical Center, Walnut Creek, at 1601 Ygnacio Valley Rd, Walnut Creek, CA 94598 in Contra Costa County. The practice phone is (925) 939-3000.

Dr. Bertoni's primary practice is John Muir Medical Center, Walnut Creek in Walnut Creek, California, part of John Muir Health. Dr. Bertoni is also affiliated with Concord Medical Center. The medical group on file is BASS Medical Group. Dmand AI also links Dr. Bertoni to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bertoni practices, 4 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Bertoni's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Bertoni is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Bertoni's licenses on file in 4 states: California, Oregon, Connecticut and Louisiana.

Dmand AI lists mastectomy among the conditions Dr. Bertoni treats.

CMS data shows 299 Medicare services from Dr. Bertoni across 9 procedure codes in 2024, for 126 Medicare patients. Medicare paid $54,149 for them.

CMS counts 126 Medicare patients who saw Dr. Bertoni in 2024. The largest group is 65 to 74, with 63 patients. 75% of them have high cholesterol, and 71% have cancer. Their average risk score is 0.99, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bertoni's median patient age at 56, with 96% women.

In 2024, Dr. Bertoni wrote 12 Medicare Part D claims. 92% of them were for generic drugs. They cover 3 drugs, with $251 in total drug cost. In 2022, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Bertoni for performance year 2024, reported individually. Dr. Bertoni accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bertoni as offering telehealth. CMS counts 26 procedures of mastectomy by Dr. Bertoni, more than 84% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Bertoni, published from 2015 to 2019. 2015 was the busiest year, with 2. The most frequent topics are Lymphatic Metastasis, Lymph Nodes and Mastectomy. Dr. Bertoni has published most often in Ann Surg Oncol. Dr. Bertoni's most frequent co-authors are Irene Leonor Wapnir, MD, Dung Hoang Nguyen and Donald Rowe Lannin, MD.

Dmand AI links Dr. Bertoni to 3 clinical trials, 2 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Breast Neoplasms and Breast Diseases. Alliance for Clinical Trials in Oncology sponsors the most, 2.

CMS Open Payments shows 204 general payments to Dr. Bertoni from 57 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 73% of the total. Hologic Inc paid the most, $2,144.

Dmand AI lists 1 award for Dr. Bertoni.

Dr. Bertoni graduated from Rutgers New Jersey Medical School in 2007. Dr. Bertoni is a member of ACS.

Dr. Bertoni is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.